Literature DB >> 14226093

THE USE OF LYSERGIC ACID DIETHYLAMIDE (LSD) IN PSYCHOTHERAPY.

E F BAKER.   

Abstract

One hundred of 150 patients with non-psychotic functional psychiatric disorders were benefited by the use of LSD psychotherapy. The dosage of LSD employed was 25 to 2000 micrograms intramuscularly per session for from one to 10 sessions. On this regimen four patients became psychotic and required electroconvulsive therapy. None were permanently harmed.Indications for and contraindications to this form of treatment and a procedure involving a doctor and a nurse as co-therapists are discussed. In particular, LSD is considered to permit "perceptualization of the transference".LSD possibly extends the scope and value of the psychotherapeutic approach in such cases.

Entities:  

Keywords:  CHLORPROMAZINE; CONVULSIONS; LYSERGIC ACID DIETHYLAMIDE; NEUROSES; PERCEPTION; PERSONALITY; PSYCHOPHARMACOLOGY; PSYCHOSES; PSYCHOSES, MANIC-DEPRESSIVE; PSYCHOTHERAPY; TOXICOLOGIC REPORT

Mesh:

Substances:

Year:  1964        PMID: 14226093      PMCID: PMC1928491     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  1 in total

1.  Pharmacology of lysergic acid diethylamide and some of its related compounds.

Authors:  E ROTHLIN
Journal:  J Pharm Pharmacol       Date:  1957-09       Impact factor: 3.765

  1 in total
  2 in total

Review 1.  Lysergic acid diethylamide: a drug of 'use'?

Authors:  Saibal Das; Preeti Barnwal; Anand Ramasamy; Sumalya Sen; Somnath Mondal
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-23

Review 2.  On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.

Authors:  Richard J Zeifman; Nikhita Singhal; Leah Breslow; Cory R Weissman
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.